CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer
Authors:
Open Access
- 11 September 2022
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1877 (5) , 188799
Abstract
No abstract availableKeywords
This publication has 250 references indexed in Scilit:
- Germinal Center Centroblasts Transition to a Centrocyte Phenotype According to a Timed Program and Depend on the Dark Zone for Effective SelectionImmunity, 2013
- Differential G protein subunit expression by prostate cancer cells and their interaction with CXCR5Molecular Cancer, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Inhibition of follicular T-helper cells by CD8+ regulatory T cells is essential for self toleranceNature, 2010
- The chemokine receptor CXCR5 is pivotal for ectopic mucosa-associated lymphoid tissue neogenesis in chronic Helicobacter pylori-induced inflammationJournal of Molecular Medicine, 2010
- Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic miceInternational Journal of Cancer, 2009
- Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell linesInternational Journal of Cancer, 2009
- Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesionCancer Letters, 2009
- Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patientsBritish Journal of Cancer, 2008
- Gene expression profiling in human gastric mucosa infected with Helicobacter pyloriLaboratory Investigation, 2007